BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34674794)

  • 1. Monoclonal antibody K312-based depletion of pluripotent cells from differentiated stem cell progeny prevents teratoma formation.
    Park J; Lee DG; Lee NG; Kwon MG; Son YS; Son MY; Bae KH; Lee J; Park JG; Lee NK; Min JK
    BMB Rep; 2022 Mar; 55(3):142-147. PubMed ID: 34674794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluripotent stem cells: Basic biology or else differentiations aimed at translational research and the role of flow cytometry.
    Bose B; Nihad M; P SS
    Cytometry A; 2023 May; 103(5):368-377. PubMed ID: 36918734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a decoy immunization strategy to identify cell-surface molecules expressed on undifferentiated human embryonic stem cells.
    Choi HS; Kim H; Won A; Kim JJ; Son CY; Kim KS; Ko JH; Lee MY; Kim CH; Ryu CJ
    Cell Tissue Res; 2008 Aug; 333(2):197-206. PubMed ID: 18560898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic population derived from human pluripotent stem cells is effectively increased by selective removal of undifferentiated stem cells using YM155.
    Kang SJ; Park YI; Hwang SR; Yi H; Tham N; Ku HO; Song JY; Kang HG
    Stem Cell Res Ther; 2017 Apr; 8(1):78. PubMed ID: 28412976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue inhibitor of metalloproteinase proteins inhibit teratoma growth in mice transplanted with pluripotent stem cells.
    Choi KA; Park HK; Hwang I; Jeong H; Park HS; Jang AY; Namkung Y; Hyun D; Lee S; Yoo BM; Kwon HJ; Seol KC; Kim JO; Hong S
    Stem Cells; 2020 Apr; 38(4):516-529. PubMed ID: 31778275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells.
    Tang C; Lee AS; Volkmer JP; Sahoo D; Nag D; Mosley AR; Inlay MA; Ardehali R; Chavez SL; Pera RR; Behr B; Wu JC; Weissman IL; Drukker M
    Nat Biotechnol; 2011 Aug; 29(9):829-34. PubMed ID: 21841799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo surveillance and elimination of teratoma-forming human embryonic stem cells with monoclonal antibody 2448 targeting annexin A2.
    Tan HL; Tan BZ; Goh WXT; Cua S; Choo A
    Biotechnol Bioeng; 2019 Nov; 116(11):2996-3005. PubMed ID: 31388993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible caspase-9 suicide gene under control of endogenous oct4 to safeguard mouse and human pluripotent stem cell therapy.
    Liu Y; Yang Y; Suo Y; Li C; Chen M; Zheng S; Li H; Tang C; Fan N; Lan T; Zhou J; Li Y; Wang J; Chen H; Zou Q; Lai L
    Mol Ther Methods Clin Dev; 2022 Mar; 24():332-341. PubMed ID: 35229007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heightened potency of human pluripotent stem cell lines created by transient BMP4 exposure.
    Yang Y; Adachi K; Sheridan MA; Alexenko AP; Schust DJ; Schulz LC; Ezashi T; Roberts RM
    Proc Natl Acad Sci U S A; 2015 May; 112(18):E2337-46. PubMed ID: 25870291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
    Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC
    J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardization of the teratoma assay for analysis of pluripotency of human ES cells and biosafety of their differentiated progeny.
    Gropp M; Shilo V; Vainer G; Gov M; Gil Y; Khaner H; Matzrafi L; Idelson M; Kopolovic J; Zak NB; Reubinoff BE
    PLoS One; 2012; 7(9):e45532. PubMed ID: 23049812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of pluripotent stem cells from nascent undifferentiated teratoma.
    An Y; Sekinaka T; Tando Y; Okamura D; Tanaka K; Ito-Matsuoka Y; Takehara A; Yaegashi N; Matsui Y
    Dev Biol; 2019 Feb; 446(1):43-55. PubMed ID: 30529251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DSG2 Is a Functional Cell Surface Marker for Identification and Isolation of Human Pluripotent Stem Cells.
    Park J; Son Y; Lee NG; Lee K; Lee DG; Song J; Lee J; Kim S; Cho MJ; Jang JH; Lee J; Park JG; Kim YG; Kim JS; Lee J; Cho YS; Park YJ; Han BS; Bae KH; Han S; Kang B; Haam S; Lee SH; Lee SC; Min JK
    Stem Cell Reports; 2018 Jul; 11(1):115-127. PubMed ID: 29910125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine pluripotent stem cells that escape differentiation inside teratomas maintain pluripotency.
    Pei Y; Yue L; Zhang W; Xiang J; Ma Z; Han J
    PeerJ; 2018; 6():e4177. PubMed ID: 29312817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and characterization of 2-E2-specific surface protein in human pluripotent stem cells.
    Kim H; Choi HS; Kim CH; Ryu CJ
    Hybridoma (Larchmt); 2011 Aug; 30(4):401-4. PubMed ID: 21851243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells.
    International Stem Cell Initiative
    Nat Commun; 2018 May; 9(1):1925. PubMed ID: 29765017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded potential stem cell media as a tool to study human developmental hematopoiesis in vitro.
    Wilkinson AC; Ryan DJ; Kucinski I; Wang W; Yang J; Nestorowa S; Diamanti E; Tsang JC; Wang J; Campos LS; Yang F; Fu B; Wilson N; Liu P; Gottgens B
    Exp Hematol; 2019 Aug; 76():1-12.e5. PubMed ID: 31326613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD133 in human embryonic stem cell proliferation and teratoma formation.
    Wang H; Gong P; Li J; Fu Y; Zhou Z; Liu L
    Stem Cell Res Ther; 2020 May; 11(1):208. PubMed ID: 32460847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of clinically compliant human embryonic stem cells in an autologous feeder-free system.
    Fu X; Toh WS; Liu H; Lu K; Li M; Cao T
    Tissue Eng Part C Methods; 2011 Sep; 17(9):927-37. PubMed ID: 21561302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method for selective ablation of undifferentiated human pluripotent stem cell populations for cell-based therapies.
    Chour T; Tian L; Lau E; Thomas D; Itzhaki I; Malak O; Zhang JZ; Qin X; Wardak M; Liu Y; Chandy M; Black KE; Lam MP; Neofytou E; Wu JC
    JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.